Addition of Kisqali to drug plan in Quebec expands access to treatment for metastatic breast cancer

19 September 2019 - Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer. ...

Read more →

National pharmacare cheaper than healing people who can't afford their drugs

17 September 2019 - A national pharmacare program could potentially reduce prescription drug spending by aggregating the buying power of all ...

Read more →

Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications

16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...

Read more →

FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma

17 September 2019 - The U.S. FDA is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence.  ...

Read more →

I'm not in ...some Third World place': bladder cancer patients face ongoing scarcity of life-saving drug

16 September 2019 - Canada's only supplier, Merck, is now projecting BCG shortage will last until December 2020. ...

Read more →

Canada decides: Leading parties plan to tackle ways to make medicine affordable

16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...

Read more →

Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement

12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...

Read more →

Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans

11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...

Read more →

Why Canada can't be America's pharmacy

11 September 2019 - Canada doesn't have enough drugs to share, and it doesn't want that role. ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Canada OKs Celltrion's biosimilar

10 September 2019 - Celltrion said that Health Canada has given the go-ahead for Herzuma (trastuzumab), an anticancer antibody biosimilar, ...

Read more →

Erosion of physician and patient treatment choice continues - Alliance for Safe Biologic Medicines raises concerns for patients as British Columbia expands biologics forced switching policy

10 September 2019 - On 5 September, the Government of British Columbia announced that it would be forcibly switching 1,700 patients ...

Read more →

Canada releases final amendments to patented medicines pricing regulations

9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...

Read more →

Trudeau’s drug price overhaul is set to cost drug makers billions

6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...

Read more →

NDP promises to restore special drugs program

4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...

Read more →